Invention Grant
- Patent Title: Alpha-synuclein antibodies
-
Application No.: US16469482Application Date: 2017-12-14
-
Publication No.: US11325968B2Publication Date: 2022-05-10
- Inventor: Pekka Kallunki , Karina Fog
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Wolf, Greenfield & Sacks, P.C.
- Priority: DKPA201600769 20161216
- International Application: PCT/EP2017/082749 WO 20171214
- International Announcement: WO2018/109058 WO 20180621
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61P25/16
Abstract:
The present invention relates to a mouse antibody denoted m2E6, chimeric ch2E6, as well as to 3 humanized forms (2E6-HLD1, 2E6-HLD2 and 2E6-HLD3) and affinity matured forms of HLD1: 7A10, 5A1, 9D7, 9G11, 7C4, L3, 8D9, 9C12 or 6B6 to create higher affinity antibodies.
Public/Granted literature
- US20200024337A1 AGENTS, USES AND METHODS Public/Granted day:2020-01-23
Information query
